Semaglutide is available in oral (Rybelsus) and injectable (Ozempic/Wegovy) forms. The injectables result in weight losses of ...

Patients are stuck in a loop between pharmacies and doctors trying to fill prescriptions for vital medicines which are ...

A particular formulation of semaglutide is presenting hazards that a major pharmaceutical company is warning customers about.

Danish pharma giant Novo Nordisk has said it is aware of at least 10 deaths and 100 hospitalisations linked to compounded ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales.

NVO's third-quarter revenues are expected to have been driven by its diabetes and obesity care product sales, especially Wegovy, Ozempic and Rybelsus.

Videos about cheap supplements that cause fat to 'drop off' or lead to a 'flat tummy in seven days' have been viewed by ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...